Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Not Confirmed
Not Confirmed
06-10 December, 2025
CPhI Middle EastCPhI Middle East
Not Confirmed
Not Confirmed
08-10 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Industry Trade Show
Not Confirmed
06-10 December, 2025
CPhI Middle EastCPhI Middle East
Industry Trade Show
Not Confirmed
08-10 December, 2025
Digital content

27 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-presents-latest-preclinical-data-of-atg-201-cd19-x-cd3-tce-at-acr-2025-302593950.html

20 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-presents-latest-atg-022-clinical-data-at-esmo-2025-demonstrating-efficacy-across-all-cldn18-2-expression-levels-and-exceptional-tolerability-302588391.html

19 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-to-present-latest-preclinical-results-from-atg-201-cd19xcd3-tce-at-acr-2025-302561416.html

23 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-announces-2025-interim-financial-results-highlighting-encouraging-data-from-midlate-stage-clinical-programs-and-its-innovative-tce-technology-platform-302536610.html

19 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengenes-atg-022-cldn18-2-adc-granted-breakthrough-therapy-designation-for-the-treatment-of-gastricgastroesophageal-junction-adenocarcinoma-302533326.html

23 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-to-present-latest-clinical-results-from-two-studies-in-cpi-resistant-solid-tumors-at-asco-2025-302463999.html
ABOUT THIS PAGE